Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Meagher

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2025
Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC studyWei Chen, Hajime Tanaka, Masaki Kobayashi, et al.
World Journal of Urology|September 6, 2024
Comparison of outcomes of radical and partial nephrectomy for sarcomatoid renal cell carcinoma: analysis of the national cancer databaseLuke L Wang, Kit L Yuen, Cesare Saitta, et al.
World Journal of Urology|January 29, 2026
Partial nephrectomy for clinical T2b, T3a, and T3b renal mass: evaluating trifecta achievement and surgical outcomesGiacomo Musso, Margaret F Meagher, Ryan Nasseri, et al.
Clinical Genitourinary Cancer|March 28, 2021
Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)Sunil H Patel, Ithaar H Derweesh, Kazutaka Saito, et al.
JAMA Network Open|July 16, 2021
Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care ActJuan F Javier-DesLoges, Julia Yuan, Shady Soliman, et al.
Urologic Oncology|May 9, 2025
Reclassification of pathologically upstaged T3a Renal Cell Carcinoma is associated with enhanced alignment of outcomes: Analysis of the National Cancer DatabaseDhruv Puri, Brian R Lane, Natalie Birouty, et al.
World Journal of Urology|January 9, 2025
Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) RegistryWei Chen, Hajime Tanaka, Masaki Kobayashi, et al.
Clinical Genitourinary Cancer|August 28, 2025
The Influence of Lymphovascular Invasion on T Stage Upstaging and Overall Survival in Renal Cell Carcinoma: A Population-Based StudyGiacomo Musso, Giuseppe Garofano, Mai Dabbas, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 4, 2019
Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectivesSean W Berquist, Kendrick Yim, Stephen T Ryan, et al.
Science (New York, N.Y.)|January 10, 2006
Variability in nocturnal nitrogen oxide processing and its role in regional air qualityS S Brown, T B Ryerson, A G Wollny, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Urology : Official Journal of the Japanese Urological Association|January 4, 2025
Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC studyWei Chen, Hajime Tanaka, Masaki Kobayashi, et al.
World Journal of Urology|September 6, 2024
Comparison of outcomes of radical and partial nephrectomy for sarcomatoid renal cell carcinoma: analysis of the national cancer databaseLuke L Wang, Kit L Yuen, Cesare Saitta, et al.
World Journal of Urology|January 29, 2026
Partial nephrectomy for clinical T2b, T3a, and T3b renal mass: evaluating trifecta achievement and surgical outcomesGiacomo Musso, Margaret F Meagher, Ryan Nasseri, et al.
Clinical Genitourinary Cancer|March 28, 2021
Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)Sunil H Patel, Ithaar H Derweesh, Kazutaka Saito, et al.
JAMA Network Open|July 16, 2021
Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care ActJuan F Javier-DesLoges, Julia Yuan, Shady Soliman, et al.
Urologic Oncology|May 9, 2025
Reclassification of pathologically upstaged T3a Renal Cell Carcinoma is associated with enhanced alignment of outcomes: Analysis of the National Cancer DatabaseDhruv Puri, Brian R Lane, Natalie Birouty, et al.
World Journal of Urology|January 9, 2025
Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) RegistryWei Chen, Hajime Tanaka, Masaki Kobayashi, et al.
Clinical Genitourinary Cancer|August 28, 2025
The Influence of Lymphovascular Invasion on T Stage Upstaging and Overall Survival in Renal Cell Carcinoma: A Population-Based StudyGiacomo Musso, Giuseppe Garofano, Mai Dabbas, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 4, 2019
Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectivesSean W Berquist, Kendrick Yim, Stephen T Ryan, et al.
Science (New York, N.Y.)|January 10, 2006
Variability in nocturnal nitrogen oxide processing and its role in regional air qualityS S Brown, T B Ryerson, A G Wollny, et al.
Pageof 9